NewAmsterdam Pharma Company N.V. - NAMS Quarterly Revenue Growth

NewAmsterdam Pharma Company (NAMS) - corporate logo

NewAmsterdam Pharma (NAMS) is optimizing global supplies of cardiovascular drugs, leveraging a strong team of scientists and regulatory experts. The quarterly revenue growth rate demonstrates income dynamics, while the value of 5395.90 serves as the current metric. The company's developments in combating metabolic disorders and lowering cholesterol are being integrated into care standards, preventing dangerous cardiovascular pathologies.

NAMS NewAmsterdam Pharma N.V. Quarterly Sales Growth Rate (06/21/2023 - 11/20/2026)

Financial and market metric breakdowns for NewAmsterdam Pharma Company N.V. (NAMS)

- current quotes and average value forecast:
- cash and cash flow indicators:
Basic company analysis:newamsterdampharma.com - NAMS
Mass-produced product of newamsterdampharma.com

NewAmsterdam Pharma's transition toward the commercialization of statin alternatives for cholesterol management makes quarterly sales volume dynamics a key indicator of business scaling. This metric measures the revenue growth rate for the current quarter relative to the same period last year, allowing investors to distinguish a phase of active expansive growth from a dangerous slowdown in operations prior to a potential correction in asset value.

Competitor analysis

ASND - Revenue Growth QoQ|MDGL: Revenue Growth QoQ|CORT: Quarterly Revenue Growth|RYTM - Quarterly Sales Growth Rate|Revenue Growth QoQ Akero Corp|Metsera Therapeutics (MTSR) - Quarterly Sales Growth Rate|Revenue Growth QoQ moonlaketx.com (MLTX)|Quarterly Sales Growth Crinetics Pharmaceuticals CRNX|Revenue Growth QoQ Soleno Therapeutics Inc SLNO|Quarterly Revenue Growth Amicus Therapeutics Inc FOLD|89bio Corp - Quarterly Revenue Growth|Revenue Change vs Previous Quarter Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Revenue Growth QoQ|Quarterly Sales Growth MiMedx Group, Inc.|Revenue Growth QoQ Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Quarterly Sales Growth Rate|Quarterly Revenue Growth MBX|Quarterly Sales Growth Altimmune, Inc. ALT|Quarterly Revenue Growth AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Quarterly Revenue Growth Rate|BIOA: Quarterly Sales Growth|Quarterly Revenue Increase BMEA (Biomea Fusion)|QNCX (quincetx.com) - Quarterly Sales Growth|Fractyl - Quarterly Revenue Increase|VTVT (vTv Therapeutics Inc) - Quarterly Revenue Growth|Agape ATP - Revenue Dynamics QoQ|Quarterly Sales Growth PLUR (Pluri Inc)|Quarterly Sales Growth Rate Synlogic Inc.|Revenue Growth QoQ Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Quarterly Revenue Growth Rate|Spruce Biosciences Inc. - Quarterly Revenue Growth|Quarterly Sales Growth Rate Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Revenue Growth QoQ|Lumos Pharma - Quarterly Revenue Increase|ONVO (Organovo Corp) - Quarterly Revenue Growth|Radius Pharmaceuticals (RDUS) - Quarterly Sales Growth Rate